NCT04068077View on ClinicalTrials.gov

Application of High Resolution Optical Coherence Tomography in Skin Disease: Amyloidosis and Differential Diagnosis

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 8, 2019

Primary Completion Date

December 19, 2019

Study Completion Date

December 19, 2019

Conditions
Amyloidosis
Interventions
DEVICE

ApolloVue™ S100 image system, Viper1-S003

The device is an in vivo non-invasive optical coherence tomography and will be used to obtain at least 6 medical images of normal and lesional skin, respectively, for experimental group.

Trial Locations (1)

11217

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
collaborator

Apollo Medical Optics, Ltd

INDUSTRY

lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

NCT04068077 - Application of High Resolution Optical Coherence Tomography in Skin Disease: Amyloidosis and Differential Diagnosis | Biotech Hunter | Biotech Hunter